e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Airway inflammation: pharmacological mechanisms and novel targets
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development
S. Schneider (Freiburg, Germany), S. Cicko (Vienna, Austria), A. Zech (Vienna, Austria), M. Hoßfeld (Freiburg, Germany), M. Idzko (Vienna, Austria)
Source:
International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Session:
Airway inflammation: pharmacological mechanisms and novel targets
Session type:
Thematic Poster
Number:
4218
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Schneider (Freiburg, Germany), S. Cicko (Vienna, Austria), A. Zech (Vienna, Austria), M. Hoßfeld (Freiburg, Germany), M. Idzko (Vienna, Austria). P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development. 4218
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Cigarette smoke-induced emphysema occurs in the absence of TLR4-signalling in a murine model of COPD
Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Year: 2008
Cigarette smoke-induced pulmonary inflammation, but not airway wall remodeling, is attenuated in CCR5 deficient mice
Source: Annual Congress 2007 - The best of airway epithelial cells
Year: 2007
Disruption of pulmonary lipid homeostasis drives cigarette smoke-induced lung inflammation in mice
Source: Eur Respir J 2015; 46: 1451-1460
Year: 2015
Tiotropium inhalation prevents acute cigarette smoke-induced airway inflammation in mice
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009
Role of activin-A in cigarette smoke-induced inflammation and COPD
Source: Eur Respir J 2014; 43: 1028-1041
Year: 2014
Characterisation of a sub-acute mouse model of cigarette smoke extract-induced lung inflammation
Source: Annual Congress 2007 - The best of airway epithelial cells
Year: 2007
Cigarette smoke induced pulmonary emphysema is attenuated in CCR6 deficient mice
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006
LPS accelerates cigarette smoke-induced deterioration in respiratory function and airway inflammation in mice
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007
Role of lymphotoxin-alpha in cigarette smoke-induced inflammation and lymphoid neogenesis
Source: Eur Respir J 2009; 33: 405-416
Year: 2009
Mitochondria-targeted H2S suppresses and reverses cigarette smoke-induced inflammasome activity and lung injury in experimental COPD
Source: ERS Lung Science Conference 2020
Year: 2020
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
Aclidinium inhibits cigarette smoke-induced lung fibroblast-to-myofibroblast transition
Source: Eur Respir J 2013; 41: 1264-1274
Year: 2013
Chronic intermittent hypoxia exacerbates lung fibrosis in bleomycin-induced lung injury mouse model
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018
Acute cigarette smoke exposure in mice promotes airway inflammation consistent with the hallmarks of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 80s
Year: 2003
Ceramide-1-phosphate inhibits cigarette smoke-induced airway inflammation
Source: Eur Respir J 2015; 45: 1669-1680
Year: 2015
Cigarette smoke induces peribronchial lymphoid follicles in the absence of TLR4 signalling
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006
Irisin secreted from muscle by exercise ameliorates emphysema of cigarette smoke-induced COPD in mice.
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019
Sirtuin3 reduces acute lung inflammation and emphysematous aggravation in COPD exacerbation mouse model
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019
Involvement of NCOA4-mediated ferritinophagy in cigarette smoke-induced ferroptosis in COPD pathogenesis
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept